Calumet Specialty Products Partners LP: Declaration of Change of Beneficial Ownership – Form 4







Property Submission

FORM 4

Check this box if you are no longer subject to section 16, the obligations of Form 4 or Form 5 may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN THE EFFECTIVE BENEFICIARIES OF THE SHARES Filed under Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average charge hours per response…0.5

1. Name and address of reporting person *

Sheets Daniel L

2. Name of issuer and stock symbol or trading symbol
Calumet, LP Specialty Product Partners [CLMT]

5. Relationship between the reporting person(s) and the issuer
(Check all that apply)

__X__ Director

_____ 10% Owner

_____ Officer (indicate title below)

_____ Other (specify below)

(Last)

(First)

(Environment)

2780 WATERFRONT PKWY. DR E., SUITE 200

3. Date of first transaction (month/day/year)

(Street)

INDIANAPOLIS

IN

46214

4. In case of modification, date of filing of the original (month/day/year)

6. Individual or joint/group filing (check applicable row)
_X_ Form filed by a reporting person
___ Form filed by more than one declarant

Table I – Non-derivative securities acquired, sold or beneficially owned

1. Title of guarantee

2. Transaction date (month/day/year)

2A. Deemed execution date, if applicable (month/day/year)

3. Transaction code

4. Securities acquired (A) or transferred (D)

5. Amount of securities beneficially owned as a result of the reported transaction(s)

6. Form of ownership: direct (D) or indirect (I)

7. Nature of Indirect Beneficial Ownership

Coded

V

Rising

(A) or (D)

Price

Table II – Beneficial ownership derivative securities (for exampleputs, calls, warrants, options, convertible securities)
(for exampleputs, calls, warrants, options, convertible securities)

1. Title of derivative title

2. Conversion or exercise price of the derivative security

3. Transaction date (month/day/year)

3A. Deemed execution date, if applicable (month/day/year)

4. Transaction code

5. Number of derivative securities acquired (A) or sold (D)

6. Exercise date and expiry date

7. Title and amount of the securities underlying the derivative securities

8. Price of derivative securities

9. Number of derivative securities beneficially owned as a result of reported transactions

10. Form of ownership of derivative securities: direct (D) or indirect (I)

11. Nature of Indirect Beneficial Ownership

Coded

V

(A)

(D)

Exercise date

Expiration date

Title

Amount or number of shares

Reporting owners

Name/address of declaring owner Relationships

Director

10% Owner

Officer

Other

Sheets Daniel L
2780 WATERFRONT PKWY. DR E., SUITE 200

INDIANAPOLIS, IN46214

X

Signatures

/s/ Vincent Donargo, as agent

2022-08-04

**Signature of declaring person

Date

Explanation of answers:

If the form is completed by several declarants, see

Section 5(b)(v).

(**) Intentional misrepresentation or omission of facts are federal criminal offenses. See

18 USC 1001 and 15 USC 78ff(a).

(1)

Each phantom unit is the economic equivalent of a Calumet Specialty Products Partners, LP common unit.

(2)

Each phantom unit becomes payable in the form of an ordinary unit or its cash value on the date specified by the reporting person or on the date of the reporting person’s termination of employment. Ghost units are 100% acquired.

(3)

Each Phantom Unit becomes payable in the form of a Common Unit or its cash value on the date specified by the Reporting Person or on the Reporting Person’s termination date pursuant to the Deferred Compensation Plan. 25% of phantom units vest on July 1 of each year beginning July 1, 2023. Note: Submit three copies of this form, one of which must be manually signed. If space is insufficient, See

Instruction 6 for the procedure. Potential individuals who need to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

Disclaimer Calumet Specialty Products LP Partners published this content on August 04, 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unmodified, onAugust 04, 2022 20:30:37 UTC

.

Public now 2022

All news about CALUMET SPECIALTY PRODUCTS PARTNERS, LP

Analyst recommendations on CALUMET SPECIALTY PRODUCTS PARTNERS, LP

2022 sales
4,317 million
2022 net income
-70.6M
Net debt 2022
1,222 million
PER 2022 ratio
-14.9x 2022 return
Capitalization
1,041 million
1,041 million
EV / Sales 2022
0.52x EV / Sales 2023
0.50x # of employees
1,450 Floating

78.4%

Chart CALUMET SPECIALTY PRODUCTS PARTNERS, LP









Calumet Specialty Products Partners, LP Technical Analysis Chart |  MarketScreener

Calumet Specialty Products Partners, LP Technical Analysis Chart | MarketScreener

Trends in technical analysis CALUMET SPECIALTY PRODUCTS PARTNERS, LP
Short term Middle term
Long term Tendencies Bullish Neutral

Neutral


Please enable JavaScript in your browser settings to use dynamic graphics.

Sale

To buy Medium consensus
SURPASS Number of analysts
seven Last closing price
$13.15 Average target price
$24.00 Average Spread / Target

Please enable JavaScript in your browser settings to use dynamic graphics.


Comments are closed.